The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 11,859,743 | 88,026 | SH | SOLE | 88,026 | 0 | 0 | ||
AMGEN INC | COM | 031162100 | 18,538,448 | 83,499 | SH | SOLE | 83,499 | 0 | 0 | ||
BAXTER INTL INC | COM | 071813109 | 31,331,658 | 687,701 | SH | SOLE | 687,701 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 17,910,513 | 62,877 | SH | SOLE | 62,877 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 9,537,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
COMPUTER PROGRAMS & SYS INC | COM | 205306103 | 8,622,859 | 349,245 | SH | SOLE | 349,245 | 0 | 0 | ||
DANAHER CORPORATION | COM | 235851102 | 26,378,400 | 109,910 | SH | SOLE | 109,910 | 0 | 0 | ||
ENOVIS CORPORATION | COM | 194014502 | 27,430,087 | 427,793 | SH | SOLE | 427,793 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 11,666,176 | 496,433 | SH | SOLE | 496,433 | 0 | 0 | ||
MOLINA HEALTHCARE INC | COM | 60855R100 | 32,087,784 | 106,519 | SH | SOLE | 106,519 | 0 | 0 | ||
QUANTERIX CORP | COM | 74766Q101 | 11,300,797 | 501,144 | SH | SOLE | 501,144 | 0 | 0 | ||
THE CIGNA GROUP | COM | 125523100 | 31,020,611 | 110,551 | SH | SOLE | 110,551 | 0 | 0 | ||
UNUM GROUP | COM | 91529Y106 | 40,905,851 | 857,565 | SH | SOLE | 857,565 | 0 | 0 |